Background: There is growing recognition of the serious consequences of sarcopenia on the functionality and autonomy in old age. Recently, the age-related changes in several inflammatory mediators have been implicated in the pathogenesis of sarcopenia. The purposes of this systematic review were two-fold: (1) to describe the patterns of muscle strength loss with age in the general population, and (2) to quantify the loss of muscle strength in rheumatoid arthritis as representative for an underlying inflammatory state. Handgrip strength was used as a proxy for overall muscle strength. Results: Results from 114 studies (involving 90,520 subjects) and 71 studies (involving 10,529 subjects) were combined in a meta-analysis for the general and rheumatoid arthritis population respectively and standardized at an equal sex distribution. For the general population we showed that between the ages of 25 years and 95 years mean handgrip strength declined from 45.5 kg to 23.2 kg for males and from 27.1 kg to 12.8 kg for females. We noted a steeper handgrip strength decline after 50 years of age (rate of 0.37 kg/year). In the rheumatoid arthritis population handgrip strength was not associated with chronological age between the ages of 35 years and 65 years and was as low as 20.2 kg in male and 15.1 in female. Rheumatoid arthritis disease duration was inversely associated with handgrip strength. Conclusions: This meta-analysis shows distinct patterns of age-related decrease of handgrip strength in the general population. Handgrip strength is strongly associated with the presence and duration of an inflammatory state as rheumatoid arthritis. The putative link between age-related inflammation and sarcopenia mandates further study as it represents a potential target for intervention to maintain functional independence in old age.
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Introduction
Sarcopenia, age-related loss of muscle mass and strength, is highly prevalent, with reported proportions exceeding 50% in those aged 80 years and older (Iannuzzi-Sucich et al., 2002; Baumgartner et al., 1998) . This ageing phenomenon is becoming an important public health concern as it inflicts a profound functional burden on our growing elderly population and contributes to increased morbidity (Rantanen et al., 1994; Rantanen et al., 1999; Taekema et al., 2010) Ling et al., 2010). Several studies have shown that loss of muscle mass occurs as early as the fifth decade of life and accelerates in older age (Lexell et al., 1986; Janssen et al., 2000) . The etiology and pathogenesis of sarcopenia is complex and probably involves the interplay of a myriad of factors including physical inactivity, hormonal, metabolic and nutritional factors (Doherty, 2003; Morley et al., 2001) . Recent research has also implicated age-related changes in several inflammatory mediators in the pathogenesis of sarcopenia (Krabbe et al., 2004) . Similar to the ageing process, inflammatory cytokines have been shown to have a profound role in the pathogenesis of "rheumatoid cachexia", the loss of muscle mass and strength with concomitant increase in fat mass, which persists after joint inflammation improves in rheumatoid arthritis (RA) patients (Roubenoff, 2009 ). In patients with chronic inflammatory diseases such as RA, there is an accelerated loss of muscle mass and strength compared to healthy subjects (Roubenoff, 2000; Madhok et al., 1993) .
